• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Danaher Corporation

    4/29/26 4:14:44 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials
    Get the next $DHR alert in real time by email
    8-K
    DANAHER CORP /DE/ DC false 0000313616 0000313616 2026-04-22 2026-04-22 0000313616 us-gaap:CommonStockMember 2026-04-22 2026-04-22 0000313616 dhr:A0.2SeniorNotesDue2026Member 2026-04-22 2026-04-22 0000313616 dhr:A2.1SeniorNotesDue2026Member 2026-04-22 2026-04-22 0000313616 dhr:A1.2SeniorNotesDue2027Member 2026-04-22 2026-04-22 0000313616 dhr:A0.45SeniorNotesDue2028Member 2026-04-22 2026-04-22 0000313616 dhr:A2.5SeniorNotesDue2030Member 2026-04-22 2026-04-22 0000313616 dhr:A0.75SeniorNotesDue2031Member 2026-04-22 2026-04-22 0000313616 dhr:A1.35SeniorNotesDue2039Member 2026-04-22 2026-04-22 0000313616 dhr:A1.8SeniorNotesDue2049Member 2026-04-22 2026-04-22
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): April 22, 2026

     

     

     

    LOGO

    DANAHER CORPORATION

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    Delaware   001-08089   59-1995548

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    2200 Pennsylvania Avenue, N.W.,

    Suite 800W

    Washington, D.C.

      20037-1701
    (Address of Principal Executive Offices)   (Zip Code)

    202-828-0850

    (Registrant’s Telephone Number, Including Area Code)

    Not applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange
    on which registered

    Common stock, $0.01 par value   DHR   New York Stock Exchange
    0.200% Senior Notes due 2026   DHR/26   New York Stock Exchange
    2.100% Senior Notes due 2026   DHR 26   New York Stock Exchange
    1.200% Senior Notes due 2027   DHR/27   New York Stock Exchange
    0.450% Senior Notes due 2028   DHR/28   New York Stock Exchange
    2.500% Senior Notes due 2030   DHR 30   New York Stock Exchange
    0.750% Senior Notes due 2031   DHR/31   New York Stock Exchange
    1.350% Senior Notes due 2039   DHR/39   New York Stock Exchange
    1.800% Senior Notes due 2049   DHR/49   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 1.01 Entry into a Material Definitive Agreement

    On April 29, 2026, Danaher Corporation (“Danaher”) issued €500,000,000 aggregate principal amount of Floating Rate Senior Notes due 2028 (the “Floating Rate Notes”), €750,000,000 aggregate principal amount of 3.250% Senior Notes due 2030 (the “2030 Notes”), €750,000,000 aggregate principal amount of 3.625% Senior Notes due 2034 (the “2034 Notes”) and €1,000,000,000 aggregate principal amount of 4.000% Senior Notes due 2038 (the “2038 Notes” and, together with the 2030 Notes and the 2034 Notes, the “Fixed Rate Notes” and the Fixed Rate Notes, together with the Floating Rate Notes, the “Notes”), in an underwritten offering pursuant to a registration statement on Form S-3 (File No. 333-278426) filed with the Securities and Exchange Commission (the “Commission”) on April 1, 2024 (the “Registration Statement”) and a preliminary prospectus supplement and prospectus supplement filed with the Commission related to the offering of the Notes.

    The Notes were issued under that certain indenture, dated December 11, 2007 (as amended to date, the “Base Indenture”), between Danaher and The Bank of New York Mellon Trust Company, N.A., as trustee (formerly known as The Bank of New York Trust Company, N.A.) (the “Trustee”), and that certain sixth supplemental indenture dated April 29, 2026 (the “Sixth Supplemental Indenture” and together with the Base Indenture, the “Indenture”) between Danaher and the Trustee.

    The Floating Rate Notes will mature on April 29, 2028, the 2030 Notes will mature on April 29, 2030, the 2034 Notes will mature on April 29, 2034 and the 2038 Notes will mature on April 29, 2038. Interest on the Floating Rate Notes will be paid quarterly in arrears on January 29, April 29, July 29 and October 29 of each year, beginning on July 29, 2026. Interest on the 2030 Notes, the 2034 Notes and the 2038 Notes will be paid annually in arrears on April 29 of each year, commencing on April 29, 2027.

    At any time prior to March 29, 2030 (one month prior to the maturity date of the 2030 Notes), in the case of the 2030 Notes, January 29, 2034 (three months prior to the maturity date of the 2034 Notes), in the case of the 2034 Notes, or January 29, 2038 (three months prior to the maturity date of the 2038 Notes), in the case of the 2038 Notes (each such date, a “Par Call Date”), Danaher will have the right, at its option, to redeem any series of the Fixed Rate Notes, in whole or in part, at a redemption price equal to the greater of (1) 100% of the principal amount of the Fixed Rate Notes to be redeemed and (2) the sum of the present values of the remaining scheduled payments of principal and interest in respect of such Fixed Rate Notes to be redeemed (not including any portion of the payments of interest accrued and unpaid to and including the date of redemption), discounted to the date of redemption on an annual basis (ACTUAL/ACTUAL (ICMA)) at the applicable Comparable Government Bond Rate (as defined in the Indenture), plus 10 basis points, in the case of the 2030 Notes, 15 basis points, in the case of the 2034 Notes, and 15 basis points, in the case of the 2038 Notes, plus, in each case, accrued and unpaid interest on the Fixed Rate Notes being redeemed, if any, to, but excluding, the date of redemption.

    In addition, on or after the applicable Par Call Date, Danaher will have the right, at its option, to redeem each series of the Fixed Rate Notes, in whole or in part, at any time and from time to time, at a redemption price equal to 100% of the principal amount of the Fixed Rate Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption.

    If (1) Danaher does not consummate the proposed acquisition of Masimo Corporation (the “Masimo Acquisition”) on or prior to November 16, 2026 (or such later date to which the Agreement and Plan of Merger setting forth the terms of the Masimo Acquisition as in effect on April 29, 2026 (the “Merger Agreement”) may be extended in accordance with its terms), (2) the Merger Agreement is terminated prior to that date, or (3) Danaher otherwise notifies the Trustee that it will not pursue the consummation of the Masimo Acquisition, Danaher will be required to redeem, in whole and not in part, each series of the Fixed Rate Notes on the special mandatory redemption date (as such term is defined in the Indenture) at a redemption price equal to 101% of the aggregate principal amount of the Fixed Rate Notes outstanding, plus accrued and unpaid interest to, but excluding, the special mandatory redemption date.

    Upon the occurrence of a change of control triggering event (as such term is defined in the Indenture) with respect to the Notes, each holder of the Notes may require Danaher to repurchase some or all of its Notes at a purchase price equal to 101% of the principal amount of the Notes being repurchased, plus accrued and unpaid interest, if any.

     


    The Notes are general unsecured indebtedness of Danaher. The Notes rank equally in right of payment with all of Danaher’s other existing and future unsecured senior indebtedness and will rank senior to any subordinated indebtedness that Danaher may incur.

    The Indenture contains certain covenants that limit the ability of Danaher to, among other things, (i) incur certain debt secured by liens, (ii) engage in sale and leaseback transactions and (iii) consolidate, merge or sell or otherwise transfer all or substantially all its assets.

    Upon the occurrence of an event of default with respect to the Notes, which includes payment defaults, defaults in the performance of certain covenants, and bankruptcy and insolvency-related defaults, Danaher’s obligations under the Notes may be accelerated, in which case the entire principal amount of the Notes would be immediately due and payable.

    The above description of the Base Indenture and the Sixth Supplemental Indenture is qualified in its entirety by reference to the Base Indenture and the Sixth Supplemental Indenture. The Base Indenture is filed as Exhibit 4.1 and the Sixth Supplemental Indenture is filed as Exhibit 4.2 hereto. Each of the foregoing documents is incorporated herein and into the Registration Statement by reference.

    In connection with the offering of the Notes, Danaher is filing as Exhibit 5.1 hereto an opinion of counsel addressing the validity of the Notes and certain related matters. Such opinion is incorporated by reference into the Registration Statement.

    Item 8.01 Other Events

    The Notes were sold pursuant to the terms of an underwriting agreement, dated April 22, 2026 (the “Underwriting Agreement”), among Danaher and Citigroup Global Markets Limited, Merrill Lynch International, Barclays Bank PLC, Deutsche Bank AG, London Branch, Goldman Sachs & Co. LLC and the other underwriters party thereto.

    Danaher received net proceeds of approximately €2.98 billion, after deducting the underwriting discounts and estimated offering expenses payable by Danaher. Danaher intends to use the net proceeds from the sale of the Notes to pay a portion of the cash consideration payable for, and certain costs associated with, the Masimo Acquisition. Danaher may also use a portion of the net proceeds from the sale of the Notes for general corporate purposes, which may include, without limitation and in Danaher’s sole discretion, refinancing of outstanding indebtedness, working capital, capital expenditures and satisfaction of other obligations.

    The above description of the Underwriting Agreement is qualified in its entirety by reference to the full text of the Underwriting Agreement. The Underwriting Agreement is filed as Exhibit 1.1 hereto and is incorporated herein by reference.

    Item 9.01 Financial Statements and Exhibits

    The following exhibits are filed herewith, unless otherwise indicated:

     

    Exhibit No.    Description
    1.1    Underwriting Agreement, dated as of April 22, 2026, among Danaher Corporation, Citigroup Global Markets Limited, Merrill Lynch International, Barclays Bank PLC, Deutsche Bank AG, London Branch, Goldman Sachs & Co. LLC and the other underwriters party thereto.
    4.1    Indenture, dated as of December 11, 2007, between Danaher Corporation and The Bank of New York Mellon Trust Company, N.A., as trustee (formerly known as The Bank of New York Trust Company, N.A.) (incorporated by reference to Exhibit 1.2 of the Registrant’s Current Report on Form 8-K filed with the Commission on December 11, 2007).


    4.2    Sixth Supplemental Indenture, dated as of April 29, 2026, between Danaher Corporation, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee.
    5.1    Opinion of Wilmer Cutler Pickering Hale and Dorr LLP.
    23.1    Consent of Wilmer Cutler Pickering Hale and Dorr LLP (contained in Exhibit 5.1 above).
    101.INS    Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
    101.SCH    Inline XBRL Taxonomy Extension Schema Document
    101.CAL       Inline XBRL Taxonomy Extension Calculation Linkbase Document
    101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document
    101.LAB    Inline XBRL Taxonomy Extension Labels Linkbase Document
    101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document
    104    Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        DANAHER CORPORATION
    Date: April 29, 2026     By:  

    /s/ James F. O’Reilly

          Name: James F. O’Reilly
          Title: Senior Vice President, Secretary and Deputy General Counsel
    Get the next $DHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHR

    DatePrice TargetRatingAnalyst
    6/11/2026$200.00Neutral
    Piper Sandler
    6/3/2026$210.00Buy
    DZ Bank
    6/2/2026Peer Perform
    Wolfe Research
    5/26/2026$230.00Buy
    Citigroup
    5/15/2026$200.00Outperform
    RBC Capital Mkts
    12/9/2025$265.00Buy
    Goldman
    12/2/2025$270.00Overweight
    Morgan Stanley
    10/8/2025$220.00Buy → Neutral
    Rothschild & Co Redburn
    More analyst ratings

    $DHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Danaher Reports Second Quarter 2026 Results

    WASHINGTON, July 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) today announced results for the second quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key Second Quarter 2026 ResultsNet earnings were $870 million, or $1.23 per diluted common share, up 60% year-over-year.Non-GAAP adjusted diluted net earnings per common share grew 8.0% to $1.94.Revenues increased 5.5% year-over-year to $6.3 billion.Non-GAAP core revenue increased 3.0% year-over-year and non-GAAP core revenue excluding respiratory testing revenue increased 4.5% year-over-year.Operating cash flow was $1.5 billion an

    7/21/26 6:00:00 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Audax Private Equity and Linden Capital Partners Agree to Sell StatLab Medical Products to Leica Biosystems

    Linden Capital Partners ("Linden") and Audax Private Equity ("Audax"), two leading middle-market private equity firms, announced today an agreement to sell StatLab Medical Products ("StatLab" or the "Company") to Leica Biosystems, an operating company of Danaher Corporation (NYSE:DHR). The transaction is subject to customary closing conditions. Founded in 1976 and headquartered in McKinney, Texas, StatLab is a leading manufacturer of pre-analytical products spanning the full anatomic pathology workflow, delivering high-quality products and expert service to laboratories and OEM customers across the United States and Europe. During the ownership of Audax and Linden, StatLab expanded from a

    7/14/26 5:25:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central Africa

    WASHINGTON, June 29, 2026 /PRNewswire/ -- The Danaher Foundation, supported by Danaher Corporation (NYSE:DHR), today announced a $1 million commitment to support urgent, on-the-ground response to the Ebola Bundibugyo outbreak in the Democratic Republic of Congo (DRC) and Uganda through Save the Children, the International Rescue Committee (IRC) and the World Food Program USA in support of the World Food Programme (WFP). The funding will be distributed across the three organizations to enable rapid, flexible response to evolving conditions on the ground. Efforts will focus on critical needs including infection prevention, hygiene support, community-based health services and emergency food ass

    6/29/26 8:30:00 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP, Chief Accounting Officer Bouda Christopher covered exercise/tax liability with 60 shares, decreasing direct ownership by 0.65% to 9,107 units (SEC Form 4)

    4 - DANAHER CORP /DE/ (0000313616) (Issuer)

    7/16/26 5:00:57 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Director Filler Linda exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 9% to 26,829 units (SEC Form 4)

    4 - DANAHER CORP /DE/ (0000313616) (Issuer)

    7/16/26 5:00:51 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Director Zerhouni Elias A. exercised 3,298 shares at a strike of $71.88 and covered exercise/tax liability with 1,181 shares, increasing direct ownership by 5% to 45,303 units (SEC Form 4)

    4 - DANAHER CORP /DE/ (0000313616) (Issuer)

    7/16/26 5:00:45 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    SEC Filings

    View All

    Danaher Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DANAHER CORP /DE/ (0000313616) (Filer)

    7/20/26 5:55:01 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form 11-K filed by Danaher Corporation

    11-K - DANAHER CORP /DE/ (0000313616) (Filer)

    6/16/26 5:09:15 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form S-8 filed by Danaher Corporation

    S-8 - DANAHER CORP /DE/ (0000313616) (Filer)

    6/8/26 9:48:27 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on Danaher with a new price target

    Piper Sandler initiated coverage of Danaher with a rating of Neutral and set a new price target of $200.00

    6/11/26 8:10:54 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    DZ Bank initiated coverage on Danaher with a new price target

    DZ Bank initiated coverage of Danaher with a rating of Buy and set a new price target of $210.00

    6/3/26 8:10:49 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Wolfe Research resumed coverage on Danaher

    Wolfe Research resumed coverage of Danaher with a rating of Peer Perform

    6/2/26 8:32:53 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Financials

    Live finance-specific insights

    View All

    Danaher Reports Second Quarter 2026 Results

    WASHINGTON, July 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) today announced results for the second quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key Second Quarter 2026 ResultsNet earnings were $870 million, or $1.23 per diluted common share, up 60% year-over-year.Non-GAAP adjusted diluted net earnings per common share grew 8.0% to $1.94.Revenues increased 5.5% year-over-year to $6.3 billion.Non-GAAP core revenue increased 3.0% year-over-year and non-GAAP core revenue excluding respiratory testing revenue increased 4.5% year-over-year.Operating cash flow was $1.5 billion an

    7/21/26 6:00:00 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Schedules Second Quarter 2026 Earnings Conference Call

    WASHINGTON, June 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2026 on Tuesday, July 21, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.You can

    6/22/26 4:15:00 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    Danaher Completes Acquisition of Masimo Corporation

    WASHINGTON, June 10, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care treatment settings. Masimo's trusted brand, advanced sensor technology and AI-enabled patient monitoring bring complementary and powerful new capabilities to the Danaher diagnostics portfolio. As a result of the transaction, Masimo is now a wholly-owned subsidiary of Danaher and Masimo common stock has ceased trading on the Nasdaq Stock Market. Masimo will continue to operate unde

    6/10/26 8:55:00 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    $DHR
    Leadership Updates

    Live Leadership Updates

    View All

    Sirius XM Holdings Set to Join S&P MidCap 400

    NEW YORK, June 8, 2026 /PRNewswire/ -- Sirius XM Holdings Inc. (NASD: SIRI) will replace Masimo Corp. (NASD: MASI) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, June 11. S&P 500 & 100 constituent Danaher Corp. (NYSE:DHR) is acquiring Masimo in a deal expected to be completed soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective Date Index Name Action Company Name Ticker GICS Sector  June 11, 2026  S&P MidCap 400 Addition Sirius XM HoldingsSIRI Communication Services  June 11, 2026  S&P MidCap 400 Deletion MasimoMASI Health Care ABOUT S&P DOW JONES INDICESS&P Dow Jon

    6/8/26 6:09:00 PM ET
    $DHR
    $MASI
    $SIRI
    Industrial Machinery/Components
    Industrials
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Danaher To Acquire Masimo Corporation

    WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ:MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $9.9 billion including assumed indebtedness and net of acquired cash. This represents a transaction multiple of approximately 18x estimated 2027 EBITDA, or 15x 2

    2/17/26 8:00:00 AM ET
    $DHR
    $MASI
    Industrial Machinery/Components
    Industrials
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    AstroNova Appoints Jorik E. Ittmann as President and Chief Executive Officer

    Leverages Mr. Ittmann's extensive print industry and international business experience Padraig Finn, with over 16 years in the print industry, promoted to Senior Vice President, Product Identification Tom Carll, Senior Vice President, Aerospace, Thomas DeByle, CFO, and Michael Natalizia, Chief Technology Officer, round out the Executive Leadership Team Darius G. Nevin appointed Executive Chairman AstroNova, Inc. (NASDAQ:ALOT), a leading innovator in specialized print technology solutions that enable data visualization, today announced that the Board of Directors has promoted Jorik E. Ittmann to President and CEO and appointed him to the Board of Directors, both to be effective

    8/4/25 9:00:00 AM ET
    $ALOT
    $DHR
    $VLTO
    Computer peripheral equipment
    Technology
    Industrial Machinery/Components
    Industrials

    $DHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

    SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

    2/9/23 11:16:32 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Danaher Corporation (Amendment)

    SC 13G/A - DANAHER CORP /DE/ (0000313616) (Subject)

    2/9/22 3:43:35 PM ET
    $DHR
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13D/A filed by Danaher Corporation (Amendment)

    SC 13D/A - DANAHER CORP /DE/ (0000313616) (Subject)

    11/2/21 9:29:29 AM ET
    $DHR
    Industrial Machinery/Components
    Industrials